Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle Brazel

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
JTO Clinical and Research Reports|August 30, 2023
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced <i>ALK</i>- or <i>ROS1</i>-Rearranged NSCLC: A Brief ReportRohit Thummalapalli, Noura J Choudhury, Fiona Ehrich, et al.
Translational Oncology|July 29, 2023
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subsetMisako Nagasaka, Danielle Brazel, Yasmine Baca, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
JTO Clinical and Research Reports|August 30, 2023
Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced <i>ALK</i>- or <i>ROS1</i>-Rearranged NSCLC: A Brief ReportRohit Thummalapalli, Noura J Choudhury, Fiona Ehrich, et al.
Translational Oncology|July 29, 2023
Pan-tumor survey of RET fusions as detected by next-generation RNA sequencing identified RET fusion positive colorectal carcinoma as a unique molecular subsetMisako Nagasaka, Danielle Brazel, Yasmine Baca, et al.
Pageof 5